Pathophysiology of unstable angina. Role of plaque rupture and thrombosis;Fisiopatología de la angina inestable. Papel de la rotura y trombosis de la placa aterosclerótica

Revista Espanola de Cardiologia

Volumn 52, Issue SUPPL. 1, 1999, Pages 3-12

  Ortiz, Antonio Fernández ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Atherosclerosis; Pathophysiology; Thrombosis; Unstable angina

Indexed keywords

ANIMAL; ARTERIOSCLEROSIS; CORONARY ARTERY THROMBOSIS; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; ANIMALS; ARTERIOSCLEROSIS; CORONARY THROMBOSIS; HUMANS;

EID: 8844285382     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (part I). N Engl J Med 1992; 326: 242-250 y 310-318.
2. Stary HC. Composition and classification of human atherosclerotic lesions. Virchows Archiv A Pathol Anat 1992; 421: 277-290.
3. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: Characteristics of coronary atherosclerotic plaques underlying fatal occlusive trombi. Br Heart J 1983; 50: 127-134.
4. Davies MJ, Thomas A. Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N Engl J Med 1984; 310: 1.137-1.140.
5. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985; 71: 699-708.
6. Davies MJ, Thomas AC, Knapman PA, Hangartner JR. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 1986; 73: 418-427.
7. DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897-902.
8. Sherman CT, Litvack F, Grundfest W, Lee M, Hickey A, Chaux A et al. Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med 1986; 315: 913-919.
9. De Feyter PJ, Ozaki Y, Baptista J, Escaned J, Dimario C, Dejaegre PPT et al. Ischemia-related lesion characteristics in patients with stable and unstable angina: A study with intracoronary angioscopy and ultrasound. Circulation 1995; 92: 1.408-1.413.
10. Tabata H, Mizuno K, Arakawa K, Satomura K, Shibuya T, Kurita A et al. Angioscopic identification of coronary thrombus in patients with postinfarction angina. J Am Coll Cardiol 1995; 25: 1.282-1.285.
11. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
12. Caro CG, Fitzgerald JM, Schroter RC. Arterial wall shear and distribution of early atheroma in man. Nature 1969; 223: 1.159-1.160.
13. Krams R, Wentzel JJ, Oomen JAF, Schuurbiers JCH, De Feyter PJ, Serruys PW et al. Evaluation of endothelial shear stress and 3D geometry as factors determining the development of atherosclerosis and remodeling in human coronary arteries in vivo. Arterioscler Thromb Vasc Biol 1997; 17: 2.061-2.065.
14. Levesque MJ, Liepsch D, Moravec S, Nerem RM. Correlation of endothelial cell shape and wall shear stress in a stenosed dog aorta. Arteriosclerosis 1986; 6: 220-229.
15. Reidy MA, Bowyer DE. Scanning electron microscopy of arteries: the morphology of aortic endothelium in hemodynamically stressed areas associated with branches. Atherosclerosis 1977; 26: 181-194.
16. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Rosenfeld ME et al. A definition of initial, fatty streak and intermediate lesions of atherosclerosis: a report from thr Committe on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994; 89: 2.462-2.478.
17. Fernández-Ortiz A, Fuster V. Pathophysiology of coronary artery disease. Clin Geriatric Med 1996; 12: 1-21.
18. Goldstein JL, Brown MS. The low density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem 1977; 46: 897-930.
19. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979; 76: 333-337.
20. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984; 81: 3.883-3.887.
21. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ et al. Randomised controlled trial of vitamine E in patients with coronary artery disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-785.
22. Kim JA, Territo MC, Wayner E, Parhami F, Smith CW, Haberland ME et al. Parital characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidiced LDL. Arterioscler Thromb 1994; 14: 427-433.
23. Boyd AW, Wawaryk SO, Burns GF, Fecondo JV. Intercellular adhesion molecule I (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms. Proc Natl Acad Sei USA 1988; 85: 3.095-3.099.
24. Cybulsky MI, Gimbone MA. Endothelial expression of a mononuclear adhesion molecule during atherogenesis. Science 1991; 251: 788-791.
25. Shilpesh SP, Thiagarajan R, Willerson JT, Yeh E. Inhibition of α, integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques. Circulation 1998; 97: 75-81.
26. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 ia a receptor for oxidized low density lipoprotein. J Biol Chem 1993; 268: 1.811-1.816.
27. Nozaki S, Kashiwagi H, Yamashita S, Nakagawa T, Kostner B, Tomiyama Y et al. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjets. J Clin Invest 1995; 96: 1.856-1.865.
28. Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D. Cell surface expresion of mouse microsialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci USA 1996; 93: 14.833-14.838.
29. Sporn MB, Roberts AB, Wakefield LM, Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-β. J Cell Biol 1987; 105: 1.039-1.045.
30. Ross R. Atherosclerosis: a problem of the biology of the arterial wall cells and their interactions with blood components. Atherosclerosis 1981; 1: 293-311.
31. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 1991; 11: 1.223-1.230.
32. Lee RT, Berditchevski F, Cheng GC, Hemler ME. Integrin-mediated collagen matrix reorganization by cultured human vascular smooth muscle cells. Circ Res 1995; 76: 209-214.
33. Kragel AH, Reddy SG, Wittes JT, Roberts WC. Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronaries in acute myocardial infarction and sudden coronary death. Circulation 1989; 80: 1.747-1.756.
34. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr et al. A definition of advances types of atherosclerotic lesions and a historical classification of atherosclerosis: a report from the Committe of Vascular Lesions of the Council of Arteriosclerosis, American Heart Association. Circulation 1995; 92: 1.355-1.374.
35. Llorente V, Badimon L. Bases celulares y moleculares de la acumulación de colesterol en la pared vascular y su contribución a la progresión de la lesión aterosclerótica. Rev Esp Cardiol 1998; 51: 633-641.
36. Loree HM, Tobias BJ, Gibson LJ, Kamm RD, Small DM, Lee RT. Mechanical properties of model atherosclerotic lesion lipid pools. Arterioscler Thromb 1994; 14: 230-234.
37. Richardson RD, Davies MJ, Born GVR. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989; 2: 941-944.
38. Loree HM, Kamm RD, Stringfellow RG, Lee RT. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res 1992; 71: 850-858.
39. Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: a structural analysis with histopathologic correlation. Circulation 1993; 87: 1.179-1.187.
40. Shah PK, Falk E, Badimon JJ, Femdndez-Ortiz A, Mailhac A, Villareal-Levy G et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix-degrading metalloproteinases and implications for plaque ruprure. Circulation 1995; 92: 1.565-1.569.
41. Moreno P, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994; 90: 775-778.
42. Galis ZS, Sukhova GK, Libby P. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. Methodol Commun 1995; 9: 974-980.
43. Lee RT, Libby P. The unstable atheroma. Ather Thromb Vasc Biol 1997; 17: 1.859-1.867.
44. Geng Y, Wu Q, Muszynski M, Hansson GK, Libby P. Apoptosis of vascular smooth muscle cells induced by in vivo stimulation with interferon-γ, tumor necrosis factor-α, and interleukin-1β. Arterioscler Thromb Vasc Biol 1996; 16: 19-27.
45. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995; 95: 2.266-2.274.
46. Geng Y, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1β-converting enzyme. Am J Pathophysiol 1995; 147: 251-266.
47. Bennett MR, Evan GI, Schwartz SM. Apoptosis of rat vascular smooth muscel cells is regulated by p53-dependent and -independent pathways. Circ Res 1995; 77: 266-273.
48. Farb A, Burke AP, Tang AL, Liang TV, Mannan P, Smialek J et al. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996; 93: 1.354-1.363.
49. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990; 15: 1.667-1.687.
50. Davies MJ. The composition of coronary artery plaques. N Engl J Med 1997; 337: 1.312-1.314.
51. Davies MJ, Woolf N, Rowles PM, Pepper J. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J 1988; 60: 459-464.
52. Burrig KF. The endothelium of advanced atherosclerotic plaques in humans. Arterioscler Thromb 1991; 1: 1.678-1.689.
53. Fernández-Ortiz A, Fuster V. The role of thrombosis in acute coronary heart disease. En: Willich SN, Muller JE, editores. Triggering of acute coronary syndromes. Implications for prevention. Norwell, MA, USA: Kluwer Academic Publishers, 1996; 201-218.
54. Falk E, Femandez-Ortiz A. Role of thrombosis in atherosclerosis and its complications. Am J Cardiol 1995; 75: 5B-11B.
55. Badimon L, Badimon JJ, Turitto VT, Vallabhajosula S, Fuster V. Platelet thrombus formation on collagen type I: a model of deep vessel injury: influence of blood rheology, von Willebrand factor, and blood coagulation. Circulation 1988; 78: 1.431-1.442.
56. Badimon L, Badimon JJ. Mechanism of arterial thrombosis in nonparallel streamlines: platelet thrombi grow at the apex of stenotic severity injured vessel wall: experimental study in the pig model. J Clin Invest 1998; 84: 1.134-1.144.
57. Fernández-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 1994; 23: 1.562-1.569.
58. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2.839-2.843.
59. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernández-Ortiz A et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95: 594-599.
60. Fuster V. Lewis A Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994; 90: 2.126-2.146.
61. Mailhac A, Badimon JJ, Fallon JT, Fernández-Ortiz A, Meyer B, Chesebro JH et al. Effect of an eccentric severe stenosis on fibri(ogen) deposition on severity damaged vessel wall in arterial thrombosis. Relative contribution of fibri(ogen) and platelets. Circulation 1994; 90: 988-996.
62. Turitto VT, Baungartner HR, Platelet interaction with subendothelium in flowing rabbit blood: effect of blood shear rate. Microvasc Res 1979; 17: 38-54.
63. Davies SW, Marchart B, Lyons JP, Timmis AD. Irregular coronary lesion morphology after thrombosis predicts early clinical instability. J Am Coll Cardiol 1991; 18: 669-674.
64. Hackett D, Davie G, Ghierchia S, Maseri A. Intermittent coronary occlusion in acute myocardial infarction: value of combined thrombolytic and vasodilatory therapy. N Engl J Med 1987; 317: 1.055-1.059.
65. Ohman EM, Califf RM, Topol EJ, Candela R, Abbottsmith CH, Ellis S et al. Consequences of reocclusion after successful reperfusion theraphy in acute myocardial infarction. Circulation 1990; 82: 781-791.
66. Meyer BJ, Badimon JJ, Mailhac A, Fernández-Ortiz A, Chesebro JH, Fuster V et al. Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy. Circulation 1994; 90: 2.432-2.438.
67. Fitzgerald DJ, Fitzgerald GA. Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator. Proc Nat Acad Sci USA 1989; 86: 7.585-7.589.
68. Francis CW, Markham RE Jr, Barlow GH, Florack TM, DorBrynski DM, Marder VJ. Thrombin activity of fibrin thrombi and soluble plasmic derivatives. J Lab Clin Med 1983; 102: 220-230.
69. Weitz JI, Hudoba M, Massel D, Maragonore J, Hirsh J. Clot bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 1990; 86: 385-391.
70. Yao SK, Ober JC, McNatt J, Benedict C, Rosolowsky M, Andersen HV et al. ADP plays an important role in mediating platelets aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries. Circ Res 1992; 70: 39-48.
71. Larson PT, Wallen NH, Hjemdahl P. Norepinephrine-induced platelet activation in vivo is only partly counteracted by aspirin. Circulation 1994; 89: 1.951-1.957.
72. Lin H, Young DB. Opposing effects of plasma epinephrin and norepinephrin on coronary thrombosis in vivo. Circulation 1995; 91: 1.135-1.142.
73. Badimon JJ, Badimon L, Turitto VT, Fuster V. Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels: in vivo study in a rabitt model. Arterioscler Thromb 1991; 11: 395-402.
74. Frank SL, Klisak I, Sparkes RS. The apoprotein(a) gene resides on human chromosome 6q26-27 in close proximity to the homologous gene for plasminogen. Hum Genet 1988; 79: 352-356.
75. Loscalzo J. Lipoprotein(a): a unique risk factor for athero-thrombotic disease. Arteriosclerosis 1990; 10: 672-679.
76. Terres W, Tatsis E, Pfalzer B, Beil U, Beisiegel H, Hamm CW. Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation 1995; 91: 948-951.
77. Kawai C. Pathogenesis of acute myocardial infarction. Novel regulatory systems of bioactive substances in the vessel wall. Circulation 1994; 90: 1.033-1.043.
78. Schwanz CJ, Kelley JL, Valente AJ, Cayatte AJ, Sprague EA, Rozek MM. Pathogenesis of the atherosclerotic lesion: implication for diabetes mellitus. Diabetes Care 1992; 15: 1.156-1.167.
79. Lamb JYT, Latour JG, Lesperance J, Waters D. Platelet aggregation, coronary artery disease progression and future coronary events. Am J Cardiol 1994; 73: 333-338.
80. Merlini A, Bauer KA, Oltrona L, Ardissino D, Cattaneo M, Belli C et al. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994; 90: 61-68.
81. Meade TW, North WRS, Chakrabarti R, Stirling Y, Haines AP, Thompson SO. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; 1: 1.050-1.054.
82. McGill DA, Ardlie NG. The relationship between blood fibrinogen level and coronary artery disease. Cor Art Dis 1990; 1: 557-566.
83. Rosengren A, Wilhelmsen L, Wellin L, Tsipogianni A, TegerNilsson AC, Wedel H. Social influences and cardiovascular risk factor as determinat of plasma fibrinogen concentration in a general population sample of middle age men. Br Med J 1990; 330: 634-638.
84. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2.844-2.850.
85. Davies MJ, Bland JM, Hangartner JRW, Angelini A, Thomas AC. Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischemic death. Eur Heart J 1989; 10: 203-208.
86. Swindland A, Torvik A. Atherosclerotic carotid disease in asymptomatic individuals: a hystological study of 53 cases. Acta Neurol Scand 1988; 9: 202-212.
87. Ambrose JA, Tannenbaum MA, Alexopolous D, Hjemdahl-Monsen CE, Leavy J, Weiss M et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12: 56-62.
88. Little WC, Constantinescu M, Applequte RJ, Kutcher MA, Burrows MT, Kahl FR et al. Can coronary angiography predict the site of subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988; 76: 1.157-1.166.
89. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischemic death and crescendo angina. Br Heart J 1985; 53: 363-373.